tiprankstipranks
Trending News
More News >
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market
Advertisement

Gland Pharma Ltd. (GLAND) Ratios

Compare
0 Followers

Gland Pharma Ltd. Ratios

IN:GLAND's free cash flow for Q4 2025 was ₹0.62. For the 2025 fiscal year, IN:GLAND's free cash flow was decreased by ₹ and operating cash flow was ₹0.18. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
4.33 4.04 9.46 9.46 10.00
Quick Ratio
3.26 2.84 6.80 6.80 7.51
Cash Ratio
1.63 0.26 2.62 2.62 0.96
Solvency Ratio
0.52 0.58 1.13 1.13 1.85
Operating Cash Flow Ratio
0.00 0.71 0.50 0.50 1.18
Short-Term Operating Cash Flow Coverage
0.00 4.67 649.94 649.94 4.48K
Net Current Asset Value
₹ 47.09B₹ 37.08B₹ 60.82B₹ 60.82B₹ 45.31B
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.03 0.04 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.03 0.04 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
<0.01 0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.23 1.22 1.10 1.10 1.10
Debt Service Coverage Ratio
4.59 4.77 116.80 116.80 360.85
Interest Coverage Ratio
26.19 62.79 118.76 118.76 413.41
Debt to Market Cap
<0.01 0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
21.59 24.19 0.72 0.72 0.50
Net Debt to EBITDA
-1.56 0.01 -1.58 -1.58 -0.34
Profitability Margins
Gross Profit Margin
44.70%54.73%53.50%53.50%56.42%
EBIT Margin
17.97%20.46%29.27%29.27%39.07%
EBITDA Margin
25.59%26.65%33.35%33.35%41.97%
Operating Profit Margin
19.58%29.16%24.40%24.40%35.15%
Pretax Profit Margin
18.92%20.07%29.10%29.10%38.99%
Net Profit Margin
12.44%13.69%21.55%21.55%29.12%
Continuous Operations Profit Margin
12.44%13.69%21.55%21.55%29.12%
Net Income Per EBT
65.73%68.21%74.06%74.06%74.69%
EBT Per EBIT
96.61%68.84%119.24%119.24%110.92%
Return on Assets (ROA)
6.22%7.25%8.90%8.90%15.35%
Return on Equity (ROE)
7.88%8.85%9.81%9.81%16.89%
Return on Capital Employed (ROCE)
11.39%17.76%10.99%10.99%20.11%
Return on Invested Capital (ROIC)
7.33%11.82%8.14%8.14%15.02%
Return on Tangible Assets
6.43%7.49%8.91%8.91%15.35%
Earnings Yield
2.24%2.59%3.74%3.74%2.54%
Efficiency Ratios
Receivables Turnover
3.70 3.42 3.78 3.78 5.10
Payables Turnover
3.79 2.96 2.87 2.87 3.76
Inventory Turnover
1.84 1.52 0.87 0.87 1.17
Fixed Asset Turnover
1.42 1.46 2.09 2.09 2.58
Asset Turnover
0.50 0.53 0.41 0.41 0.53
Working Capital Turnover Ratio
2.15 1.08 0.63 0.63 0.96
Cash Conversion Cycle
200.18 222.92 390.62 390.62 286.54
Days of Sales Outstanding
98.55 106.63 96.54 96.54 71.53
Days of Inventory Outstanding
198.04 239.58 421.28 421.28 311.98
Days of Payables Outstanding
96.41 123.29 127.20 127.20 96.97
Operating Cycle
296.59 346.21 517.82 517.82 383.51
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 60.52 22.11 22.11 38.27
Free Cash Flow Per Share
0.00 36.34 8.56 8.56 23.80
CapEx Per Share
0.00 23.67 13.55 13.55 14.47
Free Cash Flow to Operating Cash Flow
0.00 0.60 0.39 0.39 0.62
Dividend Paid and CapEx Coverage Ratio
0.00 2.56 1.63 1.63 2.64
Capital Expenditure Coverage Ratio
0.00 2.56 1.63 1.63 2.64
Operating Cash Flow Coverage Ratio
0.00 2.68 81.74 81.74 121.11
Operating Cash Flow to Sales Ratio
0.00 0.18 0.10 0.10 0.18
Free Cash Flow Yield
0.00%2.00%0.67%0.67%0.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
44.72 38.67 26.73 26.73 39.30
Price-to-Sales (P/S) Ratio
5.56 5.29 5.76 5.76 11.44
Price-to-Book (P/B) Ratio
3.41 3.42 2.62 2.62 6.64
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 49.91 148.24 148.24 104.15
Price-to-Operating Cash Flow Ratio
0.00 29.97 57.37 57.37 64.76
Price-to-Earnings Growth (PEG) Ratio
-53.12 -33.97 -0.75 -0.75 1.49
Price-to-Fair Value
3.41 3.42 2.62 2.62 6.64
Enterprise Value Multiple
20.17 19.88 15.70 15.70 26.92
Enterprise Value
289.92B 298.88B 189.76B 189.76B 386.89B
EV to EBITDA
20.17 19.88 15.70 15.70 26.92
EV to Sales
5.16 5.30 5.24 5.24 11.30
EV to Free Cash Flow
0.00 49.93 134.72 134.72 102.86
EV to Operating Cash Flow
0.00 29.98 52.14 52.14 63.96
Tangible Book Value Per Share
533.82 508.15 482.70 482.70 373.44
Shareholders’ Equity Per Share
555.30 529.67 483.41 483.41 373.44
Tax and Other Ratios
Effective Tax Rate
0.34 0.32 0.26 0.26 0.25
Revenue Per Share
340.83 342.54 220.16 220.16 216.58
Net Income Per Share
42.39 46.90 47.44 47.44 63.07
Tax Burden
0.66 0.68 0.74 0.74 0.75
Interest Burden
1.05 0.98 0.99 0.99 1.00
Research & Development to Revenue
0.03 0.03 0.01 0.01 <0.01
SG&A to Revenue
0.00 0.02 0.01 0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 <0.01
Income Quality
0.00 1.29 0.35 0.35 0.45
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis